InMed Pharmaceuticals
14 hedge funds and large institutions have $334K invested in InMed Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$213K | |
| 2 | +$85.7K | |
| 3 | +$16K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$5.36K |
Top Sellers
| 1 | -$18.3K | |
| 2 | -$48 | |
| 3 | -$8 | |
| 4 |
GCM
Gables Capital Management
Miami,
Florida
|
-$1 |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1 |